Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Am J Gastroenterol. 2015 Aug 25;110(9):1339–1346. doi: 10.1038/ajg.2015.220

Figure 3.

Figure 3

Hypothesized model. Colonic intraluminal pH is decreased and SCFAs production is increased suggesting higher fermentation in patients with IBS compared with HC. SCFAs are effectively absorbed (> 95% of SCFAs) in the GI tract and only a small portion (~5% of total SCFAs) is excretion in feces. Both processes can affect and are affected by intestinal transit. Abbreviations: SCFAs, short chain fatty acids; IBS, irritable bowel syndrome; HC, healthy control.